Genincode PLC
LSE:GENI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Genincode PLC
Depreciation & Amortization
Genincode PLC
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Genincode PLC
LSE:GENI
|
Depreciation & Amortization
-£347k
|
CAGR 3-Years
-105%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kooth PLC
LSE:KOO
|
Depreciation & Amortization
-£6.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
PHSC PLC
LSE:PHSC
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Iconic Labs PLC
LSE:ICON
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Trellus Health PLC
LSE:TRLS
|
Depreciation & Amortization
-$865k
|
CAGR 3-Years
-200%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genincode PLC
Glance View
GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.
See Also
What is Genincode PLC's Depreciation & Amortization?
Depreciation & Amortization
-347k
GBP
Based on the financial report for Dec 31, 2024, Genincode PLC's Depreciation & Amortization amounts to -347k GBP.
What is Genincode PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-105%
Over the last year, the Depreciation & Amortization growth was 1%. The average annual Depreciation & Amortization growth rates for Genincode PLC have been -105% over the past three years .
